Systolic Blood Pressure Time in Target Range and Incident Atrial Fibrillation in Patients With Hypertension: Insights From the SPRINT Trial.
Jue WangChao JiangSitong LiZhiyan WangYufeng WangYi-Wei LaiZhen WangWenhe LvYu BaiZejun YangQi GuoLihong HuangLiu HeXueyuan GuoSong-Nan LiNian LiuChenxi JiangRi-Bo TangDe-Yong LongXin DuCai-Hua SangChunguang QiuChang Sheng MaPublished in: Hypertension (Dallas, Tex. : 1979) (2023)
gov; Unique identifier: NCT01206062.
Keyphrases
- blood pressure
- atrial fibrillation
- hypertensive patients
- phase iii
- study protocol
- heart rate
- oral anticoagulants
- catheter ablation
- cardiovascular disease
- phase ii
- left atrial
- clinical trial
- left atrial appendage
- heart failure
- high intensity
- direct oral anticoagulants
- percutaneous coronary intervention
- resistance training
- blood glucose
- randomized controlled trial
- metabolic syndrome
- left ventricular
- adipose tissue
- venous thromboembolism
- acute coronary syndrome
- skeletal muscle
- arterial hypertension